DK4093374T3 - Kompleks af 7-deacetylforskolin og PVP - Google Patents
Kompleks af 7-deacetylforskolin og PVP Download PDFInfo
- Publication number
- DK4093374T3 DK4093374T3 DK21701961.1T DK21701961T DK4093374T3 DK 4093374 T3 DK4093374 T3 DK 4093374T3 DK 21701961 T DK21701961 T DK 21701961T DK 4093374 T3 DK4093374 T3 DK 4093374T3
- Authority
- DK
- Denmark
- Prior art keywords
- deacetylforskolin
- pvp
- complex
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20153429 | 2020-01-23 | ||
| PCT/EP2021/051499 WO2021148633A1 (de) | 2020-01-23 | 2021-01-22 | Komplex aus 7-deacetylforskolin und pvp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4093374T3 true DK4093374T3 (da) | 2024-02-05 |
Family
ID=69190714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21701961.1T DK4093374T3 (da) | 2020-01-23 | 2021-01-22 | Kompleks af 7-deacetylforskolin og PVP |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20230346956A1 (da) |
| EP (1) | EP4093374B1 (da) |
| JP (1) | JP7700133B2 (da) |
| AU (1) | AU2021211146B2 (da) |
| BR (1) | BR112022014362A2 (da) |
| CA (1) | CA3166464A1 (da) |
| DK (1) | DK4093374T3 (da) |
| ES (1) | ES2969594T3 (da) |
| FI (1) | FI4093374T3 (da) |
| HR (1) | HRP20240181T1 (da) |
| HU (1) | HUE065181T2 (da) |
| IL (1) | IL294848B1 (da) |
| LT (1) | LT4093374T (da) |
| PL (1) | PL4093374T3 (da) |
| PT (1) | PT4093374T (da) |
| RS (1) | RS65265B1 (da) |
| SI (1) | SI4093374T1 (da) |
| WO (1) | WO2021148633A1 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1294205B1 (it) | 1997-07-23 | 1999-03-24 | Farmigea Spa | Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive |
| US6960300B2 (en) * | 2003-09-08 | 2005-11-01 | Sami Labs Limited | Process for preparing water soluble diterpenes and their applications |
| JP2007210988A (ja) | 2006-02-07 | 2007-08-23 | Sabinsa Corp | ジテルペンフォルスコリン及びその誘導体で男性ホルモン及び女性ホルモンを生理学的に増大するための組成物 |
| WO2017103840A1 (en) * | 2015-12-16 | 2017-06-22 | MOHAMED ABDULLA ANZAR, Cheppattu | A water soluble 10% w/w forskolin composition and a method of synthesizing the same |
| US11234957B2 (en) * | 2017-01-09 | 2022-02-01 | SciPharm S.à.r.l | Process for preparing water soluble forskolin |
-
2021
- 2021-01-22 EP EP21701961.1A patent/EP4093374B1/de active Active
- 2021-01-22 AU AU2021211146A patent/AU2021211146B2/en active Active
- 2021-01-22 FI FIEP21701961.1T patent/FI4093374T3/en active
- 2021-01-22 JP JP2022544732A patent/JP7700133B2/ja active Active
- 2021-01-22 LT LTEPPCT/EP2021/051499T patent/LT4093374T/lt unknown
- 2021-01-22 ES ES21701961T patent/ES2969594T3/es active Active
- 2021-01-22 PL PL21701961.1T patent/PL4093374T3/pl unknown
- 2021-01-22 BR BR112022014362A patent/BR112022014362A2/pt unknown
- 2021-01-22 DK DK21701961.1T patent/DK4093374T3/da active
- 2021-01-22 SI SI202130107T patent/SI4093374T1/sl unknown
- 2021-01-22 US US17/794,946 patent/US20230346956A1/en active Pending
- 2021-01-22 HR HRP20240181TT patent/HRP20240181T1/hr unknown
- 2021-01-22 CA CA3166464A patent/CA3166464A1/en active Pending
- 2021-01-22 HU HUE21701961A patent/HUE065181T2/hu unknown
- 2021-01-22 IL IL294848A patent/IL294848B1/en unknown
- 2021-01-22 PT PT217019611T patent/PT4093374T/pt unknown
- 2021-01-22 RS RS20240156A patent/RS65265B1/sr unknown
- 2021-01-22 WO PCT/EP2021/051499 patent/WO2021148633A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4093374B1 (de) | 2023-11-15 |
| US20230346956A1 (en) | 2023-11-02 |
| HRP20240181T1 (hr) | 2024-04-26 |
| AU2021211146B2 (en) | 2026-02-12 |
| ES2969594T3 (es) | 2024-05-21 |
| RS65265B1 (sr) | 2024-03-29 |
| EP4093374A1 (de) | 2022-11-30 |
| JP7700133B2 (ja) | 2025-06-30 |
| PT4093374T (pt) | 2024-01-23 |
| IL294848B1 (en) | 2026-01-01 |
| CA3166464A1 (en) | 2021-07-29 |
| IL294848A (en) | 2022-09-01 |
| BR112022014362A2 (pt) | 2022-09-13 |
| SI4093374T1 (sl) | 2024-03-29 |
| LT4093374T (lt) | 2024-03-12 |
| JP2023511432A (ja) | 2023-03-17 |
| HUE065181T2 (hu) | 2024-05-28 |
| PL4093374T3 (pl) | 2024-04-15 |
| FI4093374T3 (en) | 2024-02-06 |
| WO2021148633A1 (de) | 2021-07-29 |
| AU2021211146A1 (en) | 2022-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4161935T3 (da) | Brm-målrettende forbindelser og tilhørende anvendelsesmetoder | |
| EP4095671A4 (en) | SCREEN VIDEO CAPTURE METHOD AND TERMINAL APPARATUS | |
| EP4472967A4 (en) | Iraqi Degradation Agents and Their Uses | |
| DK3595653T3 (da) | Sammensætninger af plinabulin og anvendelse heraf | |
| DK4196479T5 (da) | Substituerede pyridotriazinforbindelser og anvendelser deraf | |
| IL286481A (en) | Pyridazinones and methods of use thereof | |
| DK3823525T3 (da) | Måling af perfusion og iltning | |
| EP4499068A4 (en) | Iraqi Degradation Agents and Their Uses | |
| EP4024899A4 (en) | LOUDSPEAKER AND DEVICE | |
| EP4199540A4 (en) | Laser microphone and terminal | |
| DK3710485T3 (da) | Anti-sez6-antistof-lægemiddelkonjugater og anvendelsesfremgangsmåder | |
| IL309079A (en) | Methods and compositions | |
| DK3707870T3 (da) | Gruppering og anvendelse af korte sekvenssignaler | |
| EP4645974A4 (en) | POSITIONING METHODS AND POSITIONING APPARATUS | |
| DK4125842T3 (da) | Samtidig indgivelse af mirdametinib og lifirafenib til anvendelse til behandling af kræftformer | |
| DK4288426T3 (da) | Quinoxalinderivater og anvendelser deraf | |
| EP4198040C0 (de) | Pt-dpephos-iod-komplex und pt-dpephos-brom-komplex | |
| EP4244205A4 (en) | IRE1ALPHA INHIBITORS AND THEIR USES | |
| DK3651938T3 (da) | Fatning og fastgørelse af fatning | |
| DK3383068T3 (da) | Automatiseret vurdering og justering af tinnitusmaskerings indvirkning på taleforståelighed under tilpasning | |
| EP4504190A4 (en) | OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES | |
| IL312263A (en) | Lurbinectedin and atezolizumab combinations | |
| DK4190349T3 (da) | Produktion af exosomer og anvendelse heraf | |
| PL4198001T3 (pl) | Kompleks Pt-bifenyl-jod i kompleks Pt-bifenyl-brom | |
| EP4197995C0 (de) | Pt-xanthen-iod-komplex und pt-xanthen-brom-komplex |